Availability of the Draft IRIS Toxicological Review of Perfluorodecanoic Acid [PFDA, CASRN 335-76-2] and Related Salts, 21189-21190 [2023-07435]

Download as PDF Federal Register / Vol. 88, No. 68 / Monday, April 10, 2023 / Notices Regulations (18 CFR 385.211 and 385.214) on or before 5:00 p.m. Eastern time on the specified comment date. Protests may be considered, but intervention is necessary to become a party to the proceeding. eFiling is encouraged. More detailed information relating to filing requirements, interventions, protests, service, and qualifying facilities filings can be found at: https://www.ferc.gov/ docs-filing/efiling/filing-req.pdf. For other information, call (866) 208–3676 (toll free). For TTY, call (202) 502–8659. [FR Doc. 2023–07448 Filed 4–7–23; 8:45 am] BILLING CODE 6717–01–P DEPARTMENT OF ENERGY Federal Energy Regulatory Commission [Project No. 9379–013] Renewable World Energies, LLC, Grenfell, LLC; Notice of Transfer of Exemption ddrumheller on DSK120RN23PROD with NOTICES1 1. On March 6, 2023, Renewable World Energies, LLC exemptee for the 280-kilowatt Belding Dam Hydroelectric Project No. 9379, filed a letter notifying the Commission that the project was transferred from Renewable World Energies, LLC to Grenfell, LLC. The exemption from licensing was originally issued on March 17, 1986.1 The project is located on the Flat River, Ionia County, Michigan. The transfer of an exemption does not require Commission approval. 2. Grenfell, LLC is now the exemptee of the Belding Dam Hydroelectric Project No. 9379. All correspondence must be forwarded to Mr. Jason Kreuscher, Renewable World Energies Corporate Office, 100 S State Street, Neshkoro, WI 54960, Phone: 855–994– 9376 ext. 102, Email: jason@ rwehydro.com. Dated: April 4, 2023. Debbie-Anne A. Reese, Deputy Secretary. [FR Doc. 2023–07450 Filed 4–7–23; 8:45 am] BILLING CODE 6717–01–P 1 Grenfell Hydroelectric Associates, 34 FERC ¶ 62,524 (1986). Subsequently, on February 19, 2013, the project was transferred to Renewable World Energies, LLC. 18:13 Apr 07, 2023 [EPA–HQ–ORD–2019–0287; FRL–10829–01– ORD] Availability of the Draft IRIS Toxicological Review of Perfluorodecanoic Acid [PFDA, CASRN 335–76–2] and Related Salts Environmental Protection Agency (EPA). ACTION: Notice of public comment period. AGENCY: The Environmental Protection Agency (EPA) is announcing a 60-day public comment period associated with release of the draft IRIS Toxicological Review of Perfluorodecanoic Acid (PFDA, CASRN 335–76–2) and Related Salts. The draft document was prepared by the Center for Public Health and Environmental Assessment (CPHEA) within EPA’s Office of Research and Development (ORD). EPA is releasing this draft IRIS assessment for public comment in advance of a contract-led peer review. Public comments received will be provided to the external peer reviewers. ERG, a contractor to EPA, will convene a public meeting to discuss the draft report with the public during Step 4 of the IRIS Process. The external peer reviewers will consider public comments submitted in response to this notice and comments provided at a future public peer review meeting. EPA will consider all comments received when revising the document post-peer review. This draft assessment is not final as described in EPA’s information quality guidelines, and it does not represent, and should not be construed to represent Agency policy or views. DATES: The 60-day public comment period begins April 10, 2023 and ends June 9, 2023. Comments must be received on or before June 9, 2023. ADDRESSES: The IRIS Toxicological Review of Perfluorodecanoic Acid [PFDA, CASRN 335–76–2] and Related Salts will be available via the internet on the IRIS website at https:// www.epa.gov/iris/iris-recent-additions and in the public docket at https:// www.regulations.gov, Docket ID No. EPA–HQ–ORD–2019–0287. FOR FURTHER INFORMATION CONTACT: For information on the public comment period, contact the ORD Docket at the EPA Headquarters Docket Center; telephone: 202–566–1752; facsimile: 202–566–9744; or email: Docket_ORD@ epa.gov. For technical information on the IRIS Toxicological Review of SUMMARY: Dated: April 4, 2023. Debbie-Anne A. Reese, Deputy Secretary. VerDate Sep<11>2014 ENVIRONMENTAL PROTECTION AGENCY Jkt 259001 PO 00000 Frm 00018 Fmt 4703 Sfmt 4703 21189 Perfluorodecanoic Acid (PFDA, CASRN 335–76–2) and Related Salts, contact Dr. Andrew Kraft, CPHEA; telephone: 202– 564–0286; or email: kraft.andrew@ epa.gov. The IRIS Program will provide updates through the IRIS website (https://www.epa.gov/iris) and via EPA’s IRIS listserv. To register for the IRIS listserv, visit the IRIS website (https:// www.epa.gov/iris) or visit https:// www.epa.gov/iris/forms/stayingconnected-integrated-risk-informationsystem#connect. For questions about the peer review, please contact: Laurie Waite, ERG, by email at peerreview@erg.com (subject line: EPA PFAS assessments peer review); or by phone: (781) 674–7362. SUPPLEMENTARY INFORMATION: How To Submit Technical Comments to the Docket at https:// www.regulations.gov Submit your comments, identified by Docket ID No. EPA–HQ–ORD–2019– 0287 for the Perfluorodecanoic Acid IRIS Assessment, by one of the following methods: • www.regulations.gov: Follow the on-line instructions for submitting comments. • Email: Docket_ORD@epa.gov. • Fax: 202–566–9744. • Mail: U.S. Environmental Protection Agency, EPA Docket Center (ORD Docket), Mail Code: 28221T, 1200 Pennsylvania Avenue NW, Washington, DC 20460. The phone number is 202– 566–1752. For information on visiting the EPA Docket Center Public Reading Room, visit https://www.epa.gov/dockets. Due to public health concerns related to COVID–19, the EPA Docket Center and Reading Room may be closed to the public with limited exceptions. The telephone number for the Public Reading Room is 202–566–1744. The public can submit comments via www.regulations.gov or email. Instructions: Direct your comments to docket number EPA–HQ–ORD–2019– 0287 for Perfluorodecanoic Acid IRIS Assessment. Please ensure that your comments are submitted within the specified comment period. Comments received after the closing date will be marked ‘‘late,’’ and may only be considered if time permits. It is EPA’s policy to include all comments it receives in the public docket without change and to make the comments available online at www.regulations.gov, including any personal information provided, unless a comment includes information claimed to be Confidential Business Information (CBI) or other information for which disclosure is restricted by statute. Do E:\FR\FM\10APN1.SGM 10APN1 21190 Federal Register / Vol. 88, No. 68 / Monday, April 10, 2023 / Notices not submit information through www.regulations.gov or email that you consider to be CBI or otherwise protected. The www.regulations.gov website is an ‘‘anonymous access’’ system, which means EPA will not know your identity or contact information unless you provide it in the body of your comment. If you send an email comment directly to EPA without going through www.regulations.gov, your email address will be automatically captured and included as part of the comment that is placed in the public docket and made available on the internet. If you submit an electronic comment, EPA recommends that you include your name and other contact information in the body of your comment and with any disk or CD–ROM you submit. If EPA cannot read your comment due to technical difficulties and cannot contact you for clarification, EPA may not be able to consider your comment. Electronic files should avoid the use of special characters, any form of encryption, and be free of any defects or viruses. For additional information about EPA’s public docket visit the EPA Docket Center homepage at www.epa.gov/epahome/dockets.htm. Docket: Documents in the docket are listed in the www.regulations.gov index. Although listed in the index, some information is not publicly available, e.g., CBI or other information whose disclosure is restricted by statute. Certain other materials, such as copyrighted material, are publicly available only in hard copy. Publicly available docket materials are available either electronically in www.regulations.gov or in hard copy at the ORD Docket in the EPA Headquarters Docket Center. Wayne Cascio, Director, Center for Public Health & Environmental Assessment. Investigatory records compiled for law enforcement purposes and production would disclose investigative techniques. Information the premature disclosure of which would be likely to have a considerable adverse effect on the implementation of a proposed Commission action. Matters concerning participation in civil actions or proceedings or arbitration. * * * * * CONTACT PERSON FOR MORE INFORMATION: Judith Ingram, Press Officer, Telephone: (202) 694–1220. (Authority: Government in the Sunshine Act, 5 U.S.C. 552b) Vicktoria J. Allen, Deputy Secretary of the Commission. [FR Doc. 2023–07609 Filed 4–6–23; 4:15 pm] BILLING CODE 6715–01–P FEDERAL ELECTION COMMISSION Sunshine Act Meetings Thursday, April 6, 2023 at 10:00 a.m. PLACE: 1050 First Street NE, Washington, DC and virtual (This meeting was a hybrid meeting.) STATUS: This meeting was closed to the public. MATTERS CONSIDERED: Compliance matters pursuant to 52 U.S.C. 30109. Matters concerning participation in civil actions or proceedings or arbitration. * * * * * TIME AND DATE: CONTACT PERSON FOR MORE INFORMATION: Judith Ingram, Press Officer, Telephone: (202) 694–1220. (Authority: Government in the Sunshine Act, 5 U.S.C. 552b) [FR Doc. 2023–07435 Filed 4–7–23; 8:45 am] Vicktoria J. Allen, Deputy Secretary of the Commission. BILLING CODE 6560–50–P [FR Doc. 2023–07605 Filed 4–6–23; 4:15 pm] BILLING CODE 6715–01–P FEDERAL ELECTION COMMISSION Sunshine Act Meetings Tuesday, April 18, 2023 at 10:30 a.m. and its continuation at the conclusion of the open meeting on April 19, 2023. PLACE: 1050 First Street NE, Washington, DC and virtual (This meeting will be a hybrid meeting.) STATUS: This meeting will be closed to the public. MATTERS TO BE CONSIDERED: Compliance matters pursuant to 52 U.S.C. 30109. ddrumheller on DSK120RN23PROD with NOTICES1 TIME AND DATE: VerDate Sep<11>2014 18:13 Apr 07, 2023 Jkt 259001 GENERAL SERVICES ADMINISTRATION [Notice–MRB–2023–02; Docket No. GAPFAC 2022–0001; Sequence No. 2] GSA Acquisition Policy Federal Advisory Committee; Notification of Upcoming Public Meeting Office of Government-Wide Policy, General Services Administration (GSA). ACTION: Notice. AGENCY: PO 00000 Frm 00019 Fmt 4703 Sfmt 4703 GSA is providing notice of a meeting of the GSA Acquisition Policy Federal Advisory Committee (hereinafter ‘‘the Committee’’ or ‘‘the GAP FAC’’) in accordance with the requirements of the Federal Advisory Committee Act (FACA). This meeting will be open to the public, accessible via webcast and in person. Information on attending and providing written public comment is under the SUPPLEMENTARY INFORMATION section. DATES: The GAP FAC will hold a hybrid open public meeting on Thursday, May 4, 2023, from 9:30 a.m. to 12:30 p.m. Eastern Standard Time (EST). ADDRESSES: This will be a hybrid meeting accessible via webcast and in person at GSA Headquarters, (Rooms: 1459, 1460, and 1461),1800 F Street NW, Washington, DC 20405. In person seating is limited. FOR FURTHER INFORMATION CONTACT: Boris Arratia, Designated Federal Officer, Office of Government-wide Policy, 703–795–0816, or email: boris.arratia@gsa.gov; or Stephanie Hardison, Office of Government-wide Policy, 202–258–6823, or email: stephanie.hardison@gsa.gov. Additional information about the Committee, including meeting materials and agendas, will be available on-line at https://gsa.gov/policy-regulations/ policy/acquisition-policy/gsaacquisition-policy-federal-advisorycommittee. SUPPLEMENTARY INFORMATION: The Administrator of GSA established the GAP FAC as a discretionary advisory committee under agency authority in accordance with the provisions of the FACA, as amended (5 U.S.C. app 2). As America’s buyer, GSA is uniquely positioned to enable a modern, accessible, and streamlined acquisition ecosystem and a robust marketplace connecting buyers to the suppliers and businesses that meet their mission needs. The GAP FAC will assist GSA in this endeavor through expert advice on a broad range of innovative solutions to acquisition policy, workforce, and industry partnership challenges. The GAP FAC will serve as an advisory body to GSA’s Administrator on how GSA can use its acquisition tools and authorities to target the highest priority Federal acquisition challenges. The initial focus for the GAP FAC will be on driving regulatory, policy, and process changes required to embed climate and sustainability considerations in Federal acquisition. This includes examining and recommending steps GSA can take to support its workforce and industry partners in ensuring climate and SUMMARY: E:\FR\FM\10APN1.SGM 10APN1

Agencies

[Federal Register Volume 88, Number 68 (Monday, April 10, 2023)]
[Notices]
[Pages 21189-21190]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07435]


=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-ORD-2019-0287; FRL-10829-01-ORD]


Availability of the Draft IRIS Toxicological Review of 
Perfluorodecanoic Acid [PFDA, CASRN 335-76-2] and Related Salts

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of public comment period.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) is announcing a 60-
day public comment period associated with release of the draft IRIS 
Toxicological Review of Perfluorodecanoic Acid (PFDA, CASRN 335-76-2) 
and Related Salts. The draft document was prepared by the Center for 
Public Health and Environmental Assessment (CPHEA) within EPA's Office 
of Research and Development (ORD).
    EPA is releasing this draft IRIS assessment for public comment in 
advance of a contract-led peer review. Public comments received will be 
provided to the external peer reviewers. ERG, a contractor to EPA, will 
convene a public meeting to discuss the draft report with the public 
during Step 4 of the IRIS Process. The external peer reviewers will 
consider public comments submitted in response to this notice and 
comments provided at a future public peer review meeting. EPA will 
consider all comments received when revising the document post-peer 
review. This draft assessment is not final as described in EPA's 
information quality guidelines, and it does not represent, and should 
not be construed to represent Agency policy or views.

DATES: The 60-day public comment period begins April 10, 2023 and ends 
June 9, 2023. Comments must be received on or before June 9, 2023.

ADDRESSES: The IRIS Toxicological Review of Perfluorodecanoic Acid 
[PFDA, CASRN 335-76-2] and Related Salts will be available via the 
internet on the IRIS website at https://www.epa.gov/iris/iris-recent-additions and in the public docket at https://www.regulations.gov, 
Docket ID No. EPA-HQ-ORD-2019-0287.

FOR FURTHER INFORMATION CONTACT: For information on the public comment 
period, contact the ORD Docket at the EPA Headquarters Docket Center; 
telephone: 202-566-1752; facsimile: 202-566-9744; or email: 
[email protected].
    For technical information on the IRIS Toxicological Review of 
Perfluorodecanoic Acid (PFDA, CASRN 335-76-2) and Related Salts, 
contact Dr. Andrew Kraft, CPHEA; telephone: 202-564-0286; or email: 
[email protected]. The IRIS Program will provide updates through the 
IRIS website (https://www.epa.gov/iris) and via EPA's IRIS listserv. To 
register for the IRIS listserv, visit the IRIS website (https://www.epa.gov/iris) or visit https://www.epa.gov/iris/forms/staying-connected-integrated-risk-information-system#connect.
    For questions about the peer review, please contact: Laurie Waite, 
ERG, by email at [email protected] (subject line: EPA PFAS assessments 
peer review); or by phone: (781) 674-7362.

SUPPLEMENTARY INFORMATION: 

How To Submit Technical Comments to the Docket at https://www.regulations.gov

    Submit your comments, identified by Docket ID No. EPA-HQ-ORD-2019-
0287 for the Perfluorodecanoic Acid IRIS Assessment, by one of the 
following methods:
     www.regulations.gov: Follow the on-line instructions for 
submitting comments.
     Email: [email protected].
     Fax: 202-566-9744.
     Mail: U.S. Environmental Protection Agency, EPA Docket 
Center (ORD Docket), Mail Code: 28221T, 1200 Pennsylvania Avenue NW, 
Washington, DC 20460. The phone number is 202-566-1752.
    For information on visiting the EPA Docket Center Public Reading 
Room, visit https://www.epa.gov/dockets. Due to public health concerns 
related to COVID-19, the EPA Docket Center and Reading Room may be 
closed to the public with limited exceptions. The telephone number for 
the Public Reading Room is 202-566-1744. The public can submit comments 
via www.regulations.gov or email.
    Instructions: Direct your comments to docket number EPA-HQ-ORD-
2019-0287 for Perfluorodecanoic Acid IRIS Assessment.
    Please ensure that your comments are submitted within the specified 
comment period. Comments received after the closing date will be marked 
``late,'' and may only be considered if time permits. It is EPA's 
policy to include all comments it receives in the public docket without 
change and to make the comments available online at 
www.regulations.gov, including any personal information provided, 
unless a comment includes information claimed to be Confidential 
Business Information (CBI) or other information for which disclosure is 
restricted by statute. Do

[[Page 21190]]

not submit information through www.regulations.gov or email that you 
consider to be CBI or otherwise protected. The www.regulations.gov 
website is an ``anonymous access'' system, which means EPA will not 
know your identity or contact information unless you provide it in the 
body of your comment. If you send an email comment directly to EPA 
without going through www.regulations.gov, your email address will be 
automatically captured and included as part of the comment that is 
placed in the public docket and made available on the internet. If you 
submit an electronic comment, EPA recommends that you include your name 
and other contact information in the body of your comment and with any 
disk or CD-ROM you submit. If EPA cannot read your comment due to 
technical difficulties and cannot contact you for clarification, EPA 
may not be able to consider your comment. Electronic files should avoid 
the use of special characters, any form of encryption, and be free of 
any defects or viruses. For additional information about EPA's public 
docket visit the EPA Docket Center homepage at www.epa.gov/epahome/dockets.htm.
    Docket: Documents in the docket are listed in the 
www.regulations.gov index. Although listed in the index, some 
information is not publicly available, e.g., CBI or other information 
whose disclosure is restricted by statute. Certain other materials, 
such as copyrighted material, are publicly available only in hard copy. 
Publicly available docket materials are available either electronically 
in www.regulations.gov or in hard copy at the ORD Docket in the EPA 
Headquarters Docket Center.

Wayne Cascio,
Director, Center for Public Health & Environmental Assessment.
[FR Doc. 2023-07435 Filed 4-7-23; 8:45 am]
BILLING CODE 6560-50-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.